Resultado da Busca
15 de mai. de 2024 · Cytopathology has evolved significantly in the molecular and computational era, integrating next-generation sequencing techniques and artificial intelligence tools to enhance diagnostic accuracy and patient care.
- 15 May 2024
24 de mai. de 2024 · Comprehensive Cytopathology by Marluce Bibbo; David Wilbur, 2015 In the newly updated edition of Comprehensive Cytopathology, a team of international experts provides criteria and techniques in diagnosis, testing, and new insights in cytology.
27 de mai. de 2024 · This study was designed to provide a comprehensive evaluation of the performance and clinical impact of fine needle biopsy in patients with renal masses. Methods. A 5-year retrospective study of ultrasound or computer tomography (CT)-guided fine needle biopsies of renal masses diagnosed via cytopathology was conducted.
23 de mai. de 2024 · This evolution is marked by advancements in molecular cytopathology, quality-control measures, digital techniques, and the promise of artificial intelligence in aiding diagnostics, addressing challenges such as intraobserver and interobserver reproducibility, and the global shortage of pathologists.
25 de mai. de 2024 · Cystoscopy is an invasive technique that can cause irritation, pain, bleeding, and even urinary tract infections. Cytology is a non-invasive technique that examines the tumour cells in urine under a microscope, however, in the case of low-grade bladder cancer, it has low sensitivity and low diagnostic potential .
6 de mai. de 2024 · Cytology remains the main diagnostic tool for evaluating serous effusions and CSF specimens because of its cost-effectiveness, minimal side effects, and high diagnostic accuracy. The confirmation of malignancies in serous effusions or CSF offers valuable information for staging and prognosis.
11 de mai. de 2024 · Introduction. In 2024, the World Health Organization (WHO) is scheduled to publish the WHO Reporting System for Soft Tissue Cytopathology (WHORSSTC). This system establishes categories with well-defined definitions, criteria, and estimated risks of malignancy (ROMs) for soft tissue tumors.
